Cancer Medicine 2018; 7(6):2307--2318 29722170

Introduction {#cam41475-sec-0001}
============

Breast cancer is the most common cancer in women across the world. According to the WHO experts in the world each year, there are revealed from 800,000 up to 1 million new cases of breast cancer [1](#cam41475-bib-0001){ref-type="ref"}. Paget disease is a rare form of breast cancer that occurs in the mouth of the excretory ducts of the nipple. This rare abnormality occurs in 0.5--5% of all cases of breast cancer [2](#cam41475-bib-0002){ref-type="ref"}. PD is characterized by an ulcerated, ulcerated, crusted, or scaling lesion on the nipple that can extend to the areola [3](#cam41475-bib-0003){ref-type="ref"}. Paget\'s disease of the nipple is characterized by histopathological infiltration of neoplastic cells with glandular features in the epidermal layer of the nipple--areolar complex. The pathologic mechanism of PD is still unclear. However, there are two kinds of explanation of the pathologic origin of the Paget disease epidermotropic and transformation theory [4](#cam41475-bib-0004){ref-type="ref"}, [5](#cam41475-bib-0005){ref-type="ref"}. The former one considered that the cells came from the underlying ductal tumor and then move along the lactiferous ducts to the nipple. And the other theory suggested that the cells were in situ in the major lactiferous sinuses.

Characterized by malignant crusting or ulceration of the nipple, Paget disease can present in one of three ways. The first one is in conjunction with an underlying invasive cancer. The second one is in conjunction with underlying ductal carcinoma in situ (DCIS). The last one is alone without any underlying invasive breast carcinoma or DCIS [6](#cam41475-bib-0006){ref-type="ref"}. The Paget disease can be treated by central lumpectomy with breast conservation. However, the prognosis of the PD is not well. IDC is the most common breast carcinoma subtype during the world. Recent study has suggested that patients with Paget disease conjunction with invasive cancer had worse prognosis [7](#cam41475-bib-0007){ref-type="ref"}. Nevertheless, study about all these three kinds of PD is not being researched. And study on relationship between PD and the IDC is rare. Previous study described that Paget disease alone without an underlying cancer is rare, and it presents utmost 8% of patients with Paget disease [8](#cam41475-bib-0008){ref-type="ref"}.

Married persons enjoy overall better health and increase life expectancy compared the unmarried (divorced, separated, and never married) [9](#cam41475-bib-0009){ref-type="ref"}, [10](#cam41475-bib-0010){ref-type="ref"}. Previous studies have indicated a survival advantage for married persons living with cancer [11](#cam41475-bib-0011){ref-type="ref"}, [12](#cam41475-bib-0012){ref-type="ref"}, [13](#cam41475-bib-0013){ref-type="ref"}. And a research found that married men and women with cancer to have a 15% reduced risk of death [14](#cam41475-bib-0014){ref-type="ref"}. We compared with unmarried men and women in different subtypes of Paget disease. Besides the different outcomes in unmarried patients, we found the correlation between the marital status and the hormone status and the human epidermal growth factor receptor II, which can guide the individualized treatment in clinic.

Materials and Methods {#cam41475-sec-0002}
=====================

Ethics statement {#cam41475-sec-0003}
----------------

We obtained permission to access the SEER research data. The data downloaded from the SEER do not require informed patient consent. Besides, our research was approved by the Ethical Committee and Institutional Review of Fudan University Shanghai Cancer Center (FDUSCC). The methods were performed in accordance with the approved guidelines.

Data source {#cam41475-sec-0004}
-----------

We examined the data from the National Cancer Institute\'s Surveillance, Epidemiology, and End Results (SEER) program, which contains the population‐based central cancer registries of 18 geographically defined regions. For this study, we use the November 2014--18 submission.

Patient selection {#cam41475-sec-0005}
-----------------

We use the histopathology codes from the International Classification of Disease for Oncology third edition (ICD‐O‐3) to select female patients. In the ICD‐O‐3, the codes are defined as follows: code 8500 (ductal carcinoma), code 8540 (mammary Paget disease), code 8541 (Paget disease with infiltrating ductal carcinoma), and code 8543 (Paget disease with intraductal carcinoma). According to the ICD‐O‐3, we defined and choose the patients who had the PD (ICD‐O‐3 code 8540/3), PD‐IDC (ICD‐O‐3 code 85413), PD‐DCIS (ICD‐O‐3 code 8543/3), and IDC (ICD‐O‐3 code 8500/3). In this study, women who were diagnosed as all three kinds of PD and ICD between 2000 and 2013 were included (*n* = 501,631). And these identified patients included patients with PD (*n* = 469), patients with PD‐IDC (*n* = 1832), and patients with PD‐DCIS (*n* = 1130) and infiltrating ductal carcinoma (IDC) (*n* = 498,076).

Statistical analysis {#cam41475-sec-0006}
--------------------

Overall survival (OS) was measured from the date on which the first‐time definite diagnosis was made until the date of death, the date last known to be alive, or September 2013. Disease‐specific survival (DSS) was measured from the date of diagnosis to the date of death which is associated with breast carcinoma. The National Cancer Institute\'s SEER\*Stat software package (version 6.1.4; built on April 13, 2005) was used to calculate incidence rates. Baseline patient demographic characteristics and tumor information were compared using the Pearson\'s chi‐square test for categorical variables. Survival curves were plotted according to the Kaplan--Meier method and compared using the log‐rank test in a univariate analysis. Cox regression analysis was performed to compute hazard ratios and 95% confidence intervals (95% CIs) and to evaluate the effects of confounding factors. All the tests were two sided, and *P* values less than 0.05 were considered statistically significant. All the statistical analyses were performed using SPSS statistical software, version 22.0 (IBM Corp, Armonk, NY).

Results {#cam41475-sec-0007}
=======

Clinicopathological characteristics of PD {#cam41475-sec-0008}
-----------------------------------------

Overall 447,401 patients who were diagnosed with breast carcinoma were evaluated. We evaluated 447,401 patients with breast cancer. Among these patients, 443,970 were with infiltrating ductal breast carcinoma, 469 were with mammary Paget disease, 1832 were with Paget disease with infiltrating ductal carcinoma, and 1130 were with Paget disease with intraductal carcinoma. The demographics and clinicopathological characteristics of PD, PD‐IDC, and PD‐DCIS were compared with IDC. And the results are summarized in Table [1](#cam41475-tbl-0001){ref-type="table-wrap"}. Using the Pearson\'s chi‐square test, for PD and IDC, the significant variables were age (*P* \< 0.001), marital status (*P* \< 0.001), laterality (*P* \< 0.001), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001), Grade (*P* \< 0.001), AJCC stage (*P* \< 0.001), ER (estrogen receptor) status (*P* \< 0.001), PR (progesterone receptor) status (*P* \< 0.001), HER2 (human epidermal growth factor receptor 2) status (*P* \< 0.001), and whether had radiation treatment (*P* \< 0.001). For PD‐IDC and IDC, the significant characteristics were race (*P* = 0.011), marital status (*P* \< 0.001), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001), Grade (*P* \< 0.001), AJCC stage (*P* \< 0.001), ER status (*P* \< 0.001), PR status (*P* \< 0.001), HER2 status (*P* \< 0.001), and whether had radiation treatment (*P* \< 0.001). For PD‐DCIS and IDC, the considerable characteristics were age (*P* \< 0.001), marital status (*P* \< 0.001), tumor size (*P* \< 0.001), Grade (*P* \< 0.001), AJCC stage (*P* \< 0.001), ER status (*P* \< 0.001), PR status (*P* \< 0.001), HER2 status (*P* \< 0.001), and whether had radiation treatment (*P* \< 0.001).

###### 

Characteristics of patients with Paget disease and infiltrating duct carcinoma

  Clinical characteristics   PD*N*      IDC*N*    *P*‐value   PD‐IDC*N*   IDC*N*   *P*‐value   PD‐DCIS*N*   IDC*N*   *P*‐value   
  -------------------------- ---------- --------- ----------- ----------- -------- ----------- ------------ -------- ----------- ---------
  Age at diagnosis (years)   18--49     114       158,076     \<0.001     665      158,076     0.536        292      159,076     \<0.001
  50--79                     355        285,894   1167        285,894     838      285,894                                       
  Race                       White      393       360,769     0.111       1446     360,769     0.011        948      360,769     0.069
  Black                      45         41,277    206         41,277      87       41,277                                        
  Other                      31         41,924    180         41,924      95       41,924                                        
  Marital status             Married    216       243,680     \<0.001     903      243,680     \<0.001      561      243,680     \<0.001
  Not married                204        181,155   856         181,155     529      181,155                                       
  Unknown                    49         19,134    73          19,134      40       19,134                                        
  Laterality                 Left       237       224,866     \<0.001     959      224,866     0.446        614      224,866     0.066
  Right                      226        218,611   872         218,611     516      218,611                                       
  Paired site                6          409       1           409         0        409                                           
  Unknown                    0          84        0           84          0        84                                            
  Tumor size (cm)            \<2        54        25,463      \<0.001     41       25,463      \<0.001      20       25,463      \<0.001
  2.1--5                     249        280,120   1098        280,120     672      280,120                                       
  \>5                        9          7136      28          7136        6        7136                                          
  Unknown                    157        131,251   665         131,251     432      131,251                                       
  Lymph node status          Negative   158       257,428     \<0.001     807      287,428     \<0.001      645      257,428     0.539
  Positive                   311        186,542   1025        186542      485      186,542                                       
  Grade                      I          11        84,295      \<0.001     113      84,295      \<0.001      17       84,295      \<0.001
  II                         23         176,027   526         176,027     108      176,027                                       
  III                        41         160,309   1003        160,309     396      160,309                                       
  IV                         3          5015      44          5015        237      5015                                          
  Unknown                    391        18,324                146         18,324               372          18,324               
  AJCC stage                 0          83        5           \<0.001     4        5           \<0.001      160      5           \<0.001
  I                          11         70,594    153         70,594      19       70,594                                        
  II                         2          42,900    106         42,900      11       42,900                                        
  III                        4          13,995    95          13,995      3        13,995                                        
  IV                         3          6346      21          6346        1        6346                                          
  Unknown                    366        310,130   1453        310,130     936      310,130                                       
  ER status                  Negative   74        92,846      \<0.001     769      92,846      \<0.001      408      92,846      \<0.001
  Positive                   67         318,298   849         318,298     237      318,298                                       
  Borderline                 0          701       11          701         1        701                                           
  Unknown                    328        32,125    203         32,125      484      32,125                                        
  PR status                  Negative   95        136,827     \<0.001     983      136,827     \<0.001      467      136,827     \<0.001
  Positive                   37         268,719   613         268,719     138      268,719                                       
  Borderline                 0          2063      11          2063        2        2063                                          
  Unknown                    337        36,361    225         36,361      523      36,361                                        
  HER2 status                Negative   7         106,696     \<0.001     123      106,696     \<0.001      7        106,696     \<0.001
  Positive                   17         21,261    210         21,261      33       21,261                                        
  Borderline                 0          3124      8           3124        3        3124                                          
  Unknown                    445        312,889   1491        312,889     1087     312,889                                       
  Radiation                  No         384       215,199     \<0.001     1348     215,199     \<0.001      918      215,199     \<0.001
  Yes                        67         213,217   435         213,217     191      213,217                                       
  Unknown                    18         15,554    49          15,554      21       15,554                                        

AJCC, American Joint Committee on Cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; IDC, infiltrating duct carcinoma; PD‐IDC, Paget disease concomitant infiltrating duct carcinoma; PD‐DCIS, Paget disease concomitant intraductal carcinoma, unmarried group included divorced, separated, single (never married), and widowed.
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Table [2](#cam41475-tbl-0002){ref-type="table-wrap"} presents the distribution of characteristics of women with breast cancer stratified by marital status. For patients with PD, the clinicopathologic characteristics were age at diagnosis (*P* = 0.002), race (*P* = 0.027), laterality (*P* = 0.004), tumor size (*P* \< 0.001), lymph node status (*P* = 0.001) and radiation situation (*P* \< 0.001). The hormone status did not have statistical significance. However, according to the analyses, patients who were diagnosed with PD‐IDC had different statistical factors. The hormone status had statistical significance---ER status (*P* = 0.01), PR status (*P* = 0.006), and HER2 status (*P* = 0.025). Meanwhile, for patients with PD‐DCIS, the associations were different again. Among the three hormones, only HER2 had statistical significance (*P* = 0.01). Other characteristics were age (*P* \< 0.001), race (*P* = 0.012), and AJCC stage (*P* \< 0.001). Be differ from the other two subtypes, the marital status of patients with PD‐DCIS had no significant correction with the radiation status.

###### 

The association between clinical characteristics of Paget disease and marital status

  Categories                 Married (*n*)   Unmarried (*n*)   Unknown (*n*)   *P*‐value   
  -------------------------- --------------- ----------------- --------------- ----------- ---------
                             PD                                                            
  Age at diagnosis (years)   18--49          69                36              9           0.002
  50--79                     147             168               40                          
  Race                       White           187               170             36          0.027
  Black                      16              24                5                           
  Other                      13              10                8                           
  Laterality                 Left            109               113             15          0.004
  Right                      107             86                33                          
  Paired site                0               5                 1                           
  Unknown                    0               0                 0                           
  Tumor size (cm)            \<2             16                25              13          \<0.001
  2.1--5                     134             101               14                          
  \>5                        0               5                 4                           
  Unknown                    66              73                18                          
  Lymph node status          Negative        84                69              5           0.001
  Positive                   132             135               44                          
  Grade                      I               6                 5               0           0.523
  II                         10              13                0                           
  III                        22              14                5                           
  IV                         2               1                 0                           
  Unknown                    176             171               44                          
  AJCC stage                 0               49                28              6           0.177
  I                          7               3                 1                           
  II                         0               1                 1                           
  III                        2               2                 0                           
  IV                         2               1                 0                           
  Unknown                    156             169               41                          
  ER status                  Negative        33                34              7           0.249
  Positive                   38              26                3                           
  Borderline                 145             144               39                          
  Unknown                    216             204               49                          
  PR status                  Negative        48                39              8           0.641
  Positive                   18              17                2                           
  Borderline                 0               0                 0                           
  Unknown                    150             148               39                          
  HER2 status                Negative        4                 3               0           0.695
  Positive                   10              6                 1                           
  Borderline                 0               0                 0                           
  Unknown                    202             195               48                          
  Radiation                  No              174               173             37          \<0.001
  Yes                        36              27                4                           
  Unknown                    6               4                 8                           
                             PD‐IDC                                                        
  Age at diagnosis (years)   18--49          407               240             18          \<0.001
  50--79                     496             616               55                          
  Race                       White           740               653             53          \<0.001
  Black                      58              137               11                          
  Other                      105             66                9                           
  Laterality                 Left            481               443             35          0.715
  Right                      422             412               38                          
  Paired site                0               1                 0                           
  Unknown                    0               0                 0                           
  Tumor size (cm)            \<2             14                23              4           0.189
  2.1--5                     553             506               39                          
  \>5                        14              14                0                           
  Unknown                    322             313               30                          
  Lymph node status          Negative        407               366             34          0.562
  Positive                   496             490               39                          
  Grade                      I               43                67              3           0.169
  II                         266             236               24                          
  III                        498             469               36                          
  IV                         25              18                1                           
  Unknown                    71              66                9                           
  AJCC stage                 0               1                 3               0           0.411
  I                          86              60                7                           
  II                         45              58                3                           
  III                        49              41                5                           
  IV                         13              8                 0                           
  Unknown                    709             686               58                          
  ER status                  Negative        397               347             25          0.01
  Positive                   424             391               34                          
  Borderline                 3               8                 0                           
  Unknown                    79              110               14                          
  PR status                  Negative        492               456             35          0.006
  Positive                   314             279               20                          
  Borderline                 5               4                 2                           
  Unknown                    92              117               16                          
  HER2 status                Negative        56                63              4           0.025
  Positive                   114             88                8                           
  Borderline                 5               1                 2                           
  Unknown                    728             704               59                          
  Radiation                  No              634               660             45          \<0.001
  Yes                        244             174               17                          
  Unknown                    16              22                11                          
  Age at diagnosis (years)   18--49          407               240             18          \<0.001
  50--79                     496             616               55                          
  Race                       White           740               653             53          \<0.001
  Black                      58              137               11                          
  Other                      105             66                9                           
  Laterality                 Left            481               443             35          0.715
  Right                      422             412               38                          
  Paired site                0               1                 0                           
  Unknown                    0               0                 0                           
  Tumor size (cm)            \<2             14                23              4           0.189
  2.1--5                     553             506               39                          
  \>5                        14              14                0                           
  Unknown                    322             313               30                          
  Lymph node status          Negative        407               366             34          0.562
  Positive                   496             490               39                          
  Grade                      I               43                67              3           0.169
  II                         266             236               24                          
  III                        498             469               36                          
  IV                         25              18                1                           
  Unknown                    71              66                9                           
  AJCC stage                 0               1                 3               0           0.411
  I                          86              60                7                           
  II                         45              58                3                           
  III                        49              41                5                           
  IV                         13              8                 0                           
  Unknown                    709             686               58                          
  ER status                  Negative        397               347             25          0.01
  Positive                   424             391               34                          
  Borderline                 3               8                 0                           
  Unknown                    79              110               14                          
  PR status                  Negative        492               456             35          0.006
  Positive                   314             279               20                          
  Borderline                 5               4                 2                           
  Unknown                    92              117               16                          
  HER2 status                Negative        56                63              4           0.025
  Positive                   114             88                8                           
  Borderline                 5               1                 2                           
  Unknown                    728             704               59                          
  Radiation                  No              634               660             45          \<0.001
  Yes                        244             174               17                          
  Unknown                    16              22                11                          

AJCC, American Joint Committee on Cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; IDC, infiltrating duct carcinoma; PD‐IDC, Paget disease concomitant infiltrating duct carcinoma; PD‐DCIS, Paget disease concomitant intraductal carcinoma, unmarried group included divorced, separated, single (never married), and widowed.
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Comparison of survival between three subtypes of Paget disease and IDC {#cam41475-sec-0009}
----------------------------------------------------------------------

Utilizing the Kaplan--Meier method, we analyzed all these four subtypes (PD, PD‐IDC, PD‐DCIS, and IDC) of mammary carcinoma. On the basis of the OS, the different outcomes of four subtypes of breast carcinoma are shown distinctly in Figure [1](#cam41475-fig-0001){ref-type="fig"}. Patients with PD‐DCIS had the best prognosis with a 5‐year OS 83.6%. The one worse than the PD‐DCIS was IDC. The 5‐year OS of patients with IDC was 81.1%. Then, the next one was PD. The 5‐year OS of patients with PD was 72.9%. The one with worst outcomes was PD‐IDC, whose 5‐year OS was 71.4%. Then, we analyzed the cases utilizing the DSS, and the comparison of different kinds of mammary cancer is shown in Figure [2](#cam41475-fig-0002){ref-type="fig"}. The patients with PD‐DCIS had the best prognosis with a 5‐year survival rate of 98.2%. The worse one was patients with PD. Its 5‐year survival rate was 92.4%. The survival rate of patients with IDC was 91%. And patients who were diagnosed with PD‐IDC had the worst outcomes. Its 5‐year survival rate was 84.1%. Apparently, the results of the analyses based on the OS and DSS had a little difference. Based on the OS, the results showed that the prognosis of PD was worse than IDC. However, based on the DSS, the outcome of the IDC was worse than PD. Meanwhile, the prognostic indicators can be found during the univariate analysis.

![According to the ICD‐O‐3, the codes are defined: code 8500 (ductal carcinoma), code 8540 (mammary Paget disease), code 8541 (Paget disease with infiltrating ductal carcinoma), and code 8543 (Paget disease with intraductal carcinoma). Overall survival (OS) was measured from the date on which the first‐time definite diagnosis was made until the date of death, the date last known to be alive, or September 2013.](CAM4-7-2307-g001){#cam41475-fig-0001}

![According to the ICD‐O‐3, the codes are defined: code 8500 (ductal carcinoma), code 8540 (mammary Paget disease), code 8541 (Paget disease with infiltrating ductal carcinoma), and code 8543 (Paget disease with intraductal carcinoma). Disease‐specific survival (DSS) was measured from the date of diagnosis to the date of death which is associated with breast carcinoma.](CAM4-7-2307-g002){#cam41475-fig-0002}

The survival analyses in subtypes of Paget disease {#cam41475-sec-0010}
--------------------------------------------------

According to the Kaplan--Meier method and compared utilizing the log‐rank test, we analyzed the Paget disease and its indicator which were associated with the prognosis. The results of the analyses are shown in Table [3](#cam41475-tbl-0003){ref-type="table-wrap"}. For PD, indicators which had significance were age at diagnosis (*P* \< 0.001), marital status (*P* \< 0.001), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001), and AJCC stage (*P* \< 0.001). For PD‐IDC, the significant indicators were age at diagnosis, marital status, tumor size, lymph node status, Grade, AJCC stage, and ER status. Meanwhile, the significant indicators of PD‐DCIS were age at diagnosis (*P* \< 0.001), marital status (*P* \< 0.001), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001), AJCC stage (*P* \< 0.001), HER2 status (*P* \< 0.001), and radiation or not (*P* = 0.007).

###### 

Survival analyses--univariate analyses of Paget disease

  PD                         PD‐IDC        PD‐DCIS                                                                                             
  -------------------------- ------------- ------------- -------------------------- ---------- --------- -------------------------- ---------- ---------
  Age at diagnosis (years)   18--49        \<0.001       Age at diagnosis (years)   18--49     \<0.001   Age at diagnosis (years)   18--49     \<0.001
  50--79                     50--79        50--79                                                                                              
  Race                       White         0.052         Race                       White      0.296     Race                       White      0.253
  Black                      Black         Black                                                                                               
  Other                      Other         Other                                                                                               
  Marital status             Married       \<0.001       Marital status             Married    \<0.001   Marital status             Married    \<0.001
  Not married                Not married   Not married                                                                                         
  Unknown                    Unknown       Unknown                                                                                             
  Laterality                 Left          0.112         Laterality                 Left       0.561     Laterality                 Left       0.162
  Right                      Right         Right                                                                                               
  Paired site                Paired site   Paired site                                                                                         
  Unknown                    Unknown       Unknown                                                                                             
  Tumor size (cm)            \<2           \<0.001       Tumor size (cm)            \<2        \<0.001   Tumor size (cm)            \<2        \<0.001
  2.1--5                     2.1--5        2.1--5                                                                                              
  \>5                        \>5           \>5                                                                                                 
  Unknown                    Unknown       Unknown                                                                                             
  Lymph node status          Negative      \<0.001       Lymph node status          Negative   \<0.001   Lymph node status          Negative   \<0.001
  Positive                   Positive      Positive                                                                                            
  Grade                      I             0.069         Grade                      I          0.016     Grade                      I          0.313
  II                         II            II                                                                                                  
  III                        III           III                                                                                                 
  IV                         IV            IV                                                                                                  
  Unknown                    Unknown       Unknown                                                                                             
  AJCC stage                 0             \<0.001       AJCC stage                 0          \<0.001   AJCC stage                 0          \<0.001
  I                          I             I                                                                                                   
  II                         II            II                                                                                                  
  III                        III           III                                                                                                 
  IV                         IV            IV                                                                                                  
  Unknown                    Unknown       Unknown                                                                                             
  ER status                  Negative      0.954         ER status                  Negative   0.004     ER status                  Negative   0.363
  Positive                   Positive      Positive                                                                                            
  Borderline                 Borderline    Borderline                                                                                          
  Unknown                    Unknown       Unknown                                                                                             
  PR status                  Negative      0.758         PR status                  Negative   0.055     PR status                  Negative   0.565
  Positive                   Positive      Positive                                                                                            
  Borderline                 Borderline    Borderline                                                                                          
  Unknown                    Unknown       Unknown                                                                                             
  HER2 status                Negative      0.161         HER2 status                Negative   0.348     HER2 status                Negative   \<0.001
  Positive                   Positive      Positive                                                                                            
  Borderline                 Borderline    Borderline                                                                                          
  Unknown                    Unknown       Unknown                                                                                             
  Radiation                  No            0.085         Radiation                  No         0.077     Radiation                  No         0.007
  Yes                        Yes           Yes                                                                                                 
  Unknown                    Unknown       Unknown                                                                                             

AJCC, American Joint Committee on Cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; IDC, infiltrating duct carcinoma; PD‐IDC, Paget disease concomitant infiltrating duct carcinoma; PD‐DCIS, Paget disease concomitant intraductal carcinoma, unmarried group included divorced, separated, single (never married), and widowed.
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Using Cox regression analysis was performed to compute hazard ratios and 95% confidence intervals. Choosing the variates which were significant in the univariate analyses, the multivariate analysis was performed. And the results are shown in Table [4](#cam41475-tbl-0004){ref-type="table-wrap"}. For PD, significant indicators of prognosis were age at diagnosis (*P* = 0.005, HR = 0.449, 95% CI, 0.257--0.787), race (*P* = 0.014), marital status (*P* \< 0.001), tumor size (*P* = 0.033), lymph node status (*P* \< 0.001, positive, HR = 0.417, 95% CI, 0.264--0.658), and Grade (*P* = 0.042). The *P*‐value of AJCC stage was larger than 0.05 (*P* = 0.203). For PD‐IDC, variates which had prognostic significance were age at diagnosis (*P* \< 0.001, HR = 0.347, 95% CI, 0.283--0.425), marital status (*P* \< 0.001), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001, positive, HR = 0.437, 95% CI, 0.366--0.522), Grade (*P* = 0.049), AJCC stage (*P* \< 0.001), and ER status (*P* = 0.034, positive, HR = 0.453, 95% CI, 0.195--1.052). The statistic significant indicators of the patients with PD‐DCIS were age at diagnosis (*P* \< 0.001, HR = 0.309, 95% CI, 0.203--0.469), marital status (*P* \< 0.001, not married, HR = 0.504, 95% CI, 0.269--0.945), tumor size (*P* \< 0.001), lymph node status (*P* \< 0.001, positive, HR = 0.546, 95% CI, 0.424--0.704), HER2 status (*P* = 0.004, positive, HR = 9.502, 95% CI, 2.758--32.734), and radiation or not *P* = 0.001, yes, HR = 2.183, 95% CI, 0.688--6.922).

###### 

Survival analyses--multivariate analyses of Paget disease

  Variables                  Category   Hazard ratio    95% Confidence interval   *P*‐value
  -------------------------- ---------- --------------- ------------------------- -----------
  PD                                                                              
  Age at diagnosis (years)   18--49     1               Referent                  0.005
  50--79                     0.449      0.257--0.787                              
  Race                       White      1               Referent                  0.014
  Black                      3.772      1.366--10.413                             
  Other                      5.495      1756--17.2                                
  Marital status             Married    1               Referent                  \<0.001
  Not married                0.379      0.214--0.672                              
  Unknown                    0.887      0.528--1.491                              
  Tumor size (cm)            \<2        1               Referent                  0.033
  2.1--5                     1.417      0.806--2.494                              
  \>5                        0.651      0.429--0.988                              
  Unknown                    1.506      0.509--4.454                              
  Lymph node status          Negative   1               Referent                  \<0.001
  Positive                   0.417      0.264--0.658                              
  Grade                      I          1               Referent                  0.042
  II                         1.065      0.3--2.86                                 
  III                        2.537      1.239--5.139                              
  IV                         0.714      0.313--1.628                              
  Unknown                    1.404      0.189--10.436                             
  AJCC stage                 0          1               Referent                  0.203
  I                          0.795      0.353--1.793                              
  II                         0          0                                         
  III                        0          0                                         
  IV                         1.613      0.204--12.763                             
  Unknown                    5.224      1.449--18.837                             
  PD‐IDC                                                                          
  Age at diagnosis (years)   18--49     1               Referent                  \<0.001
  50--79                     0.347      0.283--0.425                              
  Race                       White      1               Referent                  0.77
  Black                      0.556      0.813--1.47                               
  Other                      0.472      0.795--1.643                              
  Marital status             Married    1               Referent                  \<0.001
  Not married                0.625      0.427--0.914                              
  Unknown                    1.053      0.728--1.523                              
  Tumor size (cm)            \<2        1               Referent                  \<0.001
  2.1--5                     2.537      1.662--3.873                              
  \>5                        0.915      0.769--1.088                              
  Unknown                    1.255      0.685--2.302                              
  Lymph node status          Negative   1               Referent                  \<0.001
  Positive                   0.437      0.366--0.522                              
  Grade                      I          1               Referent                  0.049
  II                         0.696      0.439--1.103                              
  III                        0.946      0.683--1.311                              
  IV                         1.155      0.855--1.561                              
  Unknown                    0.855      0.705--2.256                              
  AJCC stage                 0          1               Referent                  \<0.001
  I                          0          0                                         
  II                         0.548      0.256--1.172                              
  III                        0.67       0.329--1.364                              
  IV                         1.055      0.632--1.764                              
  Unknown                    4.754      2.48--9.112                               
  ER status                  Negative   1               Referent                  0.034
  Positive                   0.453      0.195--1.052                              
  Borderline                 0.438      0.19--1.007                               
  Unknown                    1.329      0.373--4.732                              
  PR status                  Negative   1               Referent                  0.212
  Positive                   2.12       0.931--4.827                              
  Borderline                 1.818      0.799--4.138                              
  Unknown                    2.477      0.66--9.29                                
  PD‐DCIS                                                                         
  Age at diagnosis (years)   18--49     1               Referent                  \<0.001
  50--79                     0.309      0.203--0.469                              
  Race                       White      1               Referent                  0.63
  Black                      1.058      0.619--1.808                              
  Other                      1.288      0.67--2.475                               
  Marital status             Married    1               Referent                  \<0.001
  Not married                0.504      0.269--0.945                              
  Unknown                    1.237      0.675--2.266                              
  Tumor size (cm)            \<2        1               Referent                  \<0.001
  2.1--5                     4.82       2.351--9.88                               
  \>5                        1.035      0.772--1.388                              
  Unknown                    1.617      0.218--11.983                             
  Lymph node status          Negative   1               Referent                  \<0.001
  Positive                   0.546      0.424--0.704                              
  Grade                      I          1               Referent                  0.332
  II                         0.35       0.085--1.447                              
  III                        0.74       0.457--1.198                              
  IV                         0.891      0.663--1.198                              
  Unknown                    0.786      0.569--1.088                              
  ER status                  Negative   1               Referent                  0.3
  Positive                   1.424      0.759--2.672                              
  Borderline                 0.922      0.486--1.749                              
  Unknown                    0.968      0.23--14.54                               
  PR status                  Negative   1               Referent                  0.898
  Positive                   0.857      0.467--1.574                              
  Borderline                 1.047      0.513--2.134                              
  Unknown                    0          0                                         
  HER2 status                Negative   1               Referent                  0.004
  Positive                   9.502      2.758--32.734                             
  Borderline                 0.614      0.084--4.466                              
  Unknown                    0          0                                         
  Radiation                  No         1               Referent                  0.001
  Yes                        2.183      0.688--6.922                              
  Unknown                    1.096      0.33--3.638                               

AJCC, American Joint Committee on Cancer; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; IDC, infiltrating duct carcinoma; PD‐IDC, Paget disease concomitant infiltrating duct carcinoma; PD‐DCIS, Paget disease concomitant intraductal carcinoma, unmarried group included divorced, separated, single (never married), and widowed.
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The association between Paget disease and patient\'s marital status {#cam41475-sec-0011}
-------------------------------------------------------------------

According to the Kaplan--Meier method and compared using the log‐rank test, we analyzed the Paget disease and the marital status. And Figure [3](#cam41475-fig-0003){ref-type="fig"} presents the correlation. For patients with PD (Fig. [3](#cam41475-fig-0003){ref-type="fig"}A), the married patients had the best prognosis with a 5‐year OS of 85.6%. The unmarried patients (included single patients who never married, widowed, divorced, and separated patients) had worse outcomes with a 5‐year OS of 65.2%. Patients whose marital status was unknown had the worst diagnosis with a 5‐year OS of 48.7%. And the difference between them had statistical significance (*P* \< 0.001). For patients who were diagnosed with PD‐IDC (Fig. [3](#cam41475-fig-0003){ref-type="fig"}B), the married patients had the best prognosis with a 5‐year OS of 78.7%. The next was patients who were unmarried with a 5‐year OS of 64.1%. For this subtype, the patients whose marital status was unknown had the almost similar 5‐year OS of 64.9%. And the difference was statistically significant as well (*P* \< 0.001). For patients with PD‐DCIS (Fig. [3](#cam41475-fig-0003){ref-type="fig"}C), the 5‐year OS was 90.8% (married), 76.3% (unmarried), and 76.2% (unknown).

![According to the Kaplan--Meier method and compared using the log‐rank test, we analyzed the Paget disease and the marital status. (A) The association between marital status and clinical prognosis in patients with PD. (B) The association between marital status and clinical prognosis in patients with PD‐IDC. (C) The association between marital status and clinical prognosis in patients with PD‐DCIS.](CAM4-7-2307-g003){#cam41475-fig-0003}

Discussion {#cam41475-sec-0012}
==========

Previous study had reported that patients who were diagnosed of Paget disease with underlying invasive cancer had poor tumor characteristics [15](#cam41475-bib-0015){ref-type="ref"}. A previous research showed that the Paget disease with underlying invasive cancer had tumors with Grade 3 histology [8](#cam41475-bib-0008){ref-type="ref"}. In 1881, Thin observed that the nipple lesion contained malignant cells which were correlated to the underlying cancer [16](#cam41475-bib-0016){ref-type="ref"}. And this observation suggested the process of intraductal extension of cancer through the major lactiferous sinuses. We call it "pagetoid spread" nowadays. Histologically, Paget cells are large cells with pale, clear cytoplasm. It has enlarged nucleoli located within the epidermis and along the basal layer. The most widely accepted hypothesis to explain the origin of Paget cells is the epidermotropic theory. And this theory considered that Paget cells are derived from an underlying mammary adenocarcinoma [17](#cam41475-bib-0017){ref-type="ref"}. Evidence supporting the epidermotropic theory is based on studies showing that Paget disease is associated with an underlying breast carcinoma in most patients [18](#cam41475-bib-0018){ref-type="ref"}, [19](#cam41475-bib-0019){ref-type="ref"}, [20](#cam41475-bib-0020){ref-type="ref"}. Binding of heregulin to its receptor on Paget cells can induce chemotaxis of these breast cancer cells, and the cells eventually migrate into the overlying nipple epidermis [21](#cam41475-bib-0021){ref-type="ref"}. It is noteworthy that Paget cells and the underlying associated ductal carcinoma share the same immunohistochemical profile [22](#cam41475-bib-0022){ref-type="ref"} and the same patterns of gene expression.

In allusion to different subtype of Paget disease, we found that the significantly associated indicators were different. Unmarried patients of PD, including those who were widowed, divorced, and never married, were at significantly great risk of existing lymph node metastasis. Meanwhile, for patients of PD‐IDC, we found that the hormone status was related to the human epidermal growth factor receptor II. However, for the patients with PD‐DCIS, only human epidermal growth factor receptor II had statistical significance. The association between marital status and these indicators was significant for every malignancy evaluated. Previous studies have linked marriage to improvements in cardiovascular, endocrine, and immune function, and marriage may be a determinant of the magnitude and presence of this effect [23](#cam41475-bib-0023){ref-type="ref"}, [24](#cam41475-bib-0024){ref-type="ref"}. Cortisol levels seem to be lower in patients with cancer who have adequate support networks, and diurnal cortisol patterns have been linked with natural killer cell count and survival in patients with cancer[25](#cam41475-bib-0025){ref-type="ref"}, [26](#cam41475-bib-0026){ref-type="ref"}, potentially providing a physiologic basis for the psychologically based data described previously [27](#cam41475-bib-0027){ref-type="ref"}. Further investigations on this subject are warranted.

However, the study also had some limitations. The SEER database did not give us enough information about the lymphovascular invasion which can be regarded as the prediction of lymph node metastasis. Besides, the follow‐up of many patients was limited. And the information of systemic therapy of the patients was lack according to the SEER system. Based on the SEER database, the HER2 status was tested from 2010; however, the cases were from 2000 to 2013. Apparently, analyses of the HER2 were limited. And it made us unable to explore the clinical significance of HER2 status. Therefore, our study was limited by lack of some information. Besides, there is potential for misclassification of marital status. We did not take into account changes of marital status which may have occurred during the follow‐up period. And this phenomenon may have influenced our results. Thus, our findings may underestimate the protective effect that marriage has on breast cancer outcome. We defined that the single category contained divorcees, widows, and never married women. However, previous studies had found that there may be some difference among groups of unmarried women. Although the difference existed, the unmarried women fare worse than the married counterparts.

In conclusion, our study showed patients with PD‐IDC have the worst prognosis. Among all these three kinds of Paget disease, unmarried patients had worse outcomes. And the marital status of patients with PD‐IDC is associated with hormone status and HER2 status. The observation underscores the importance of individualized treatment.
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